TuHURA Biosciences Future Growth
Future criteria checks 3/6
TuHURA Biosciences is forecast to grow earnings and revenue by 63.1% and 75.2% per annum respectively while EPS is expected to grow by 61.1% per annum.
Key information
63.1%
Earnings growth rate
61.1%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 75.2% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 05 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 21 | -13 | -13 | N/A | 1 |
| 12/31/2025 | N/A | -18 | -18 | N/A | 1 |
| 12/31/2024 | N/A | -17 | -17 | N/A | 1 |
| 9/30/2024 | N/A | -19 | -15 | -15 | N/A |
| 12/31/2023 | N/A | -29 | -13 | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HURA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: HURA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: HURA is expected to become profitable in the next 3 years.
Revenue vs Market: HURA is forecast to have no revenue next year.
High Growth Revenue: HURA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HURA's Return on Equity is forecast to be high in 3 years time